Muss, Hyman B.

A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer

Goss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2003) · New England Journal of Medicine

Breast Cancer Treatment StudiesEstrogen and related hormone effects

Cited by 1,795

Cellular senescence promotes adverse effects of chemotherapy and cancer relapse

Demaria, M., O'Leary, M. N., Chang, J., Shao, L., Liu, S., Alimirah, F., Koenig, K., Le, C., Mitin, N., Deal, A. M., et al. (2017) · Cancer Discovery

Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model Organisms

Cited by 1,338

Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update

Khatcheressian, J. L., Hurley, P., Bantug, E., Esserman, L. J., Grunfeld, E., Halberg, F., Hantel, A., Henry, N. L., Muss, H. B., Smith, T. J., et al. (2013) · Journal of Clinical Oncology

Breast Cancer Treatment StudiesCancer survivorship and care

Cited by 626

Developing a cancer‐specific geriatric assessment: A feasibility study

Hurria, A., Gupta, S., Zauderer, M., Zuckerman, E. L., Cohen, H. J., Muss, H., Rodin, M., Panageas, K. S., Holland, J. C., Saltz, L., et al. (2005) · Cancer

Frailty in Older AdultsNutrition and Health in Aging

Cited by 623

Validation of a prediction tool for chemotherapy toxicity in older adults with cancer

Hurria, A., Mohile, S., Gajra, A., Klepin, H., Muss, H., Chapman, A., Feng, T., Smith, D., Sun, C.-L., De Glas, N., et al. (2016) · Journal of Clinical Oncology

Frailty in Older AdultsNutrition and Health in Aging

Cited by 598

Implementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401

Hurria, A., Cirrincione, C. T., Muss, H. B., Kornblith, A. B., Barry, W., Artz, A. S., Schmieder, L., Ansari, R., Tew, W. P., Weckstein, D., et al. (2011) · Journal of Clinical Oncology

Frailty in Older AdultsNutrition and Health in Aging

Cited by 350

Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: A systematic review and meta-analysis

Nishijima, T. F., Muss, H. B., Shachar, S. S., & Moschos, S. J. (2016) · Cancer Treatment Reviews

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 293

Effect of Cytotoxic Chemotherapy on Markers of Molecular Age in Patients With Breast Cancer

Sanoff, H. K., Deal, A. M., Krishnamurthy, J., Torrice, C., Dillon, P., Sorrentino, J., Ibrahim, J. G., Jolly, T. A., Williams, G., Carey, L. A., et al. (2014) · JNCI: Journal of the National Cancer Institute

Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model Organisms

Cited by 283

Frailty index developed from a cancer-specific geriatric assessment and the association with mortality among older adults with cancer

Guerard, E. J., Deal, A. M., Chang, Y., Williams, G. R., Nyrop, K. A., Pergolotti, M., Muss, H. B., Sanoff, H. K., & Lund, J. L. (2017) · Journal of the National Comprehensive Cancer Network

Frailty in Older AdultsNutrition and Health in Aging

Cited by 168

Age-specific changes in intrinsic breast cancer subtypes: a focus on older women

Jenkins, E. O., Deal, A. M., Anders, C. K., Prat, A., Perou, C. M., Carey, L. A., & Muss, H. B. (2014) · The Oncologist

Breast Cancer Treatment StudiesBreast Lesions and Carcinomas

Cited by 165

Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-β1) increase invasion rate of tumor cells: a population study

Casey, T. M., Eneman, J., Crocker, A., White, J., Tessitore, J., Stanley, M., Harlow, S., Bunn, J. Y., Weaver, D., Muss, H., et al. (2008) · Breast Cancer Research and Treatment

TGF-β signaling in diseasesCancer Cells and Metastasis

Cited by 127

Symptom Management in Metastatic Breast Cancer

Irvin, W., Muss, H. B., & Mayer, D. K. (2011) · The Oncologist

Cancer survivorship and carePalliative and Oncologic Care

Cited by 112

Frailty and Adherence to Adjuvant Hormonal Therapy in Older Women With Breast Cancer: CALGB Protocol 369901

Sheppard, V. B., Faul, L. A., Luta, G., Clapp, J. D., Yung, R. L., Wang, J. H.-Y., Kimmick, G., Isaacs, C., Tallarico, M., Barry, W. T., et al. (2014) · Journal of Clinical Oncology

Frailty in Older AdultsBreast Cancer Treatment Studies

Cited by 91

Accelerated aging among childhood, adolescent, and young adult cancer survivors is evidenced by increased expression of p16INK4a and frailty

Smitherman, A. B., Wood, W. A., Mitin, N., Ayer Miller, V. L., Deal, A. M., Davis, I. J., Blatt, J., Gold, S. H., & Muss, H. B. (2020) · Cancer

Childhood Cancer Survivors' Quality of LifeTelomeres, Telomerase, and Senescence

Cited by 80

Physical activity communication between oncology providers and patients with early‐stage breast, colon, or prostate cancer

Nyrop, K. A., Deal, A. M., Williams, G. R., Guerard, E. J., Pergolotti, M., & Muss, H. B. (2016) · Cancer

Cancer survivorship and carePatient-Provider Communication in Healthcare

Cited by 69

Echinomycin in Recurrent and Metastatic Endometrial Carcinoma: A Phase II Trial of the Gynecologic Oncology Group

Muss, H. B., Blessing, J. A., & DuBeshter, B. (1993) · American Journal of Clinical Oncology

Endometrial and Cervical Cancer TreatmentsOvarian cancer diagnosis and treatment

Cited by 33

Echinomycin (NSC 526417) in Advanced Ovarian Cancer: A Phase II Trial of the Gynecologic Oncology Group

Muss, H. B., Blessing, J. A., Baker, V. V., Barnhill, D. R., & Adelson, M. D. (1990) · American Journal of Clinical Oncology

Ovarian cancer diagnosis and treatmentPARP inhibition in cancer therapy

Cited by 18

A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer

Mitin, N., Nyrop, K. A., Strum, S. L., Knecht, A., Carey, L. A., Reeder-Hayes, K. E., Dees, E. C., Jolly, T. A., Kimmick, G. G., Karuturi, M. S., et al. (2022) · npj Breast Cancer

Cancer Treatment and PharmacologyChemotherapy-related skin toxicity

Cited by 17

Echinomycin (NSC 526417) in Squamous-Cell Carcinoma of the Cervix: A Phase II Trial of the Gynecologic Oncology Group

Muss, H. B., Blessing, J. A., & Malfetano, J. (1990) · American Journal of Clinical Oncology

Endometrial and Cervical Cancer TreatmentsCervical Cancer and HPV Research

Cited by 11